Stock Events

Pila Pharma AB 

SEK5.1
1
-SEK0.06-1.16% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
176.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29MayExpected
Q2 2022
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.39
-0.32
-0.24
-0.17
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PILA.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden. It is developing XEN-D0501, a TRPV1 antagonist that has completed two phase 2b clinical trials for type 2 diabetes. The company was incorporated in 2014 and is based in Malmö, Sweden.
Show more...
CEO
Ms. Dorte Xenia Gram
Employees
1
Country
SE
ISIN
SE0015988274
WKN
000A3CT5N

Listings